Date: Thursday 10 Sep 2009
Abcam continues to be one of the stars of AIM. The online retailer of research grade antibodies reported more than doubled annual profits and earnings per share earlier this week.
The share price has more than quadrupled to 800p a share in less than four years and Abcam,...
Email this article to a friend
or share it with one of these popular networks:
You are here: news